AI Terminal
SuperSeed Capital Limited
Director's Dealing • Feb 16, 2022
6137_rns_2022-02-16_7ab86ffd-2952-41ca-9cd9-ebadd6a724a7.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9215B
SuperSeed Capital Limited
16 February 2022
DATE: 16 February 2022
SuperSeed Capital Limited
("SuperSeed" or the "Company")
Director/PDMR Shareholding
The Company announces the following trades in the ordinary shares of no par value in the Company ("Ordinary Shares") by Mads Jensen, Managing Director of the Company and by Yasmin Jensen, a person closely associated ("PCA"), with Mads Jensen.
The purchase of 21,020 Ordinary Shares at price of £0.95 per share by Yasmin Jensen on 15 February 2022 and the sale of 50,000 Ordinary Shares at a price of £1.00 per share by Capax Ventures Limited on 15 February 2022.
Mads Jensen directly or indirectly holds 1,617,567 Ordinary Shares in the Company, representing 81.93% of the Company's voting rights. Capex Ventures Limited, a company which is beneficially owned and controlled by Mads Jensen now holds 1,603,765 Ordinary Shares representing 80.19% of the Company's voting rights. Yasmin Jensen now holds 21,020 Ordinary Shares in the Company, representing 1.05% of the Company's voting rights.
The notification below, made in accordance with the requirements of the Market Abuse Regulation, provides further information.
The directors of the Company accept responsibility for the content of this announcement.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mrs Yasmin Jensen
2
Reason for the notification
a)
Position/status
PCA of Mads Jensen, Managing Partner
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
SuperSeed Capital Limited
b)
LEI
213800YKE3HL6M8LZP60
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary shares of no par value
ISIN: GG00BL594H32
b)
Nature of the transaction
Purchase of Ordinary shares
c)
Price(s) and volume(s)
| Price | Volume |
| £0.95 | 21,020 |
d)
Aggregated information:
Aggregated volume
Aggregated price
21,020 Ordinary shares
£19,969.00
e)
Date of the transaction
15 February 2022
f)
Place of the transaction
Aquis Stock Exchange
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mads Jensen
2
Reason for the notification
a)
Position/status
Managing Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
SuperSeed Capital Limited
b)
LEI
213800YKE3HL6M8LZP60
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary shares of no par value
ISIN: GG00BL594H32
b)
Nature of the transaction
Sale of Ordinary shares
c)
Price(s) and volume(s)
| Price | Volume |
| £1.00 | 50,000 |
d)
Aggregated information:
Aggregated volume
Aggregated price
50,000 shares
£50,000.00
e)
Date of the transaction
15 February 2022
f)
Place of the transaction
Outside a trading venue
For more information, please contact:
| SuperSeed Capital Limited | +44(0)20 3405 3060 |
| Mads Jensen, Investment Manager | |
| VSA Capital - AQSE Corporate Adviser and Broker | +44(0)20 3005 5000 |
| Corporate Finance: Andrew Raca Corporate Broking: Andrew Monk, Peter Mattsson, David Scriven |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFZGMZNVZGZZM